According to Coherent Market Insights (CMI), the global blood plasma market size is expected to more than double, increasing from USD 38.8 Bn in 2025 to USD 79.5 Bn by 2032, recording a CAGR of 10.8%.
Immunoglobulins are set to remain highly sought-after products, accounting for 35.6% of the global blood plasma market share in 2025.
By therapeutic indication, immunology segment is set to dominate the industry, holding a share of 23.2% in 2025.
Based on application, hypogammaglobulinemia segment is projected to account for nearly one-third of the global blood plasma industry share in 2025.
North America, with an estimated market share of 35.3% in 2025, is slated to dominate the global market during the forecast period.
Asia Pacific blood plasma market is expected to record the fastest growth rate over the assessment period.
Soaring Demand for Plasma-Derived Therapies Propelling Market Growth
Coherent Market Insights’ latest blood plasma market research report lists significant factors driving industry growth. Increasing demand for plasma-derived therapies is one such growth driver.
Plasma-derived therapies are becoming highly popular for treating various diseases. These include immunodeficiency disorders, hemophilia, and autoimmune diseases. As a result, demand for these treatments is rising quickly across the globe.
To meet this growing need, healthcare systems and biopharma companies are increasing plasma collection and processing. This effort is playing a major role in boosting the growth of the blood plasma market.